longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.

benzinga_article
Jul 16, 2026 at 08:34 PM
Cellyan Biotechnology shares are trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Cellyan Biotechnology

Cellyan Biotechnology

HKPD.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI